Viral Disease News and Research

RSS

Mosquito bourne diseases cause concern in three areas of Australia

Australian Health officials have issued public health warnings about mosquito bourne diseases in three areas.

25 Feb 2008

Pre-eclampsia linked to herpes virus

Australian researchers have discovered a viral link which they believe may help explain high blood pressure during pregnancy (pre-eclampsia) and pre-term birth.

18 Feb 2008

Probiotics help keep elite athletes fit and well

According to the latest Australian research the immune system of long-distance runners was enhanced by probiotics - dietary supplements containing potentially beneficial bacteria or yeasts.

13 Feb 2008

New bluetongue outbreak in the UK

A new case of bluetongue disease has appeared in the UK in the Greater London district of Watford.

11 Feb 2008

Risk factors for severe RSV infection in immunocompromised children

St. Jude Children's Research Hospital investigators and collaborators have shown how to predict if a child who is infected with respiratory syncytial virus (RSV) while being treated for cancer or another catastrophic disease is at high risk for developing severe infection. The finding will help clinicians improve guidelines for managing these infected children.

4 Feb 2008

New discovery, immune cells confront viruses just inside of the lymph node

Vaccines have led to many of the world's greatest public health triumphs, but many deadly viruses, such as HIV, still elude the best efforts of scientists to develop effective vaccines against them. An improved understanding of how the immune system operates during a viral infection is critical to designing successful anti-virus vaccines.

4 Feb 2008

Researchers find cell protein that blocks HIV virus generation

UCLA researchers have found that a key protein in the body's dendritic cells can stop the virus that causes AIDS from "budding" part of the virus' life cycle that is crucial to its ability to replicate and infect other cells.

16 Jan 2008

FDA approves Tysabri to treat Crohn's disease

The U.S. Food and Drug Administration has approved Tysabri (natalizumab) for the treatment of moderate-to-severe Crohn's disease in patients with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional Crohn's disease therapies.

14 Jan 2008

Genomic screen identifies 273 human proteins required for HIV propagation

In some ways, HIV resembles a minimalist painter, using a few basic components to achieve dramatic effects.

11 Jan 2008

Experts say children with severe pneumonia are better off being treated at home

The World Health Organisation (WHO) says children with severe pneumonia are better off being treated at home instead of sending them to hospital.

6 Jan 2008

Genetic cause of Kawasaki disease

Researchers from Japan's RIKEN SNP Research Center, collaborating with a team at the University of California, San Diego (UCSD), have discovered a new genetic variation that affects a child's risk of getting Kawasaki disease (KD), an illness characterized by acute inflammation of the arteries throughout the body.

17 Dec 2007

Ingredient found in human semen enhances HIV infection

A plentiful ingredient found in human semen drastically enhances the ability of the human immunodeficiency virus (HIV) to cause infection, according to a report in the December 14, 2007, issue of the journal Cell, a publication of Cell Press.

14 Dec 2007

Immune compound blocks virus' ability to hijack antibodies

Researchers at Washington University School of Medicine in St. Louis have shown that a controversial phenomenon known as antibody-dependent enhancement (ADE) of infection is suppressed by C1q, a blood-borne immune system compound.

13 Dec 2007

Crimean Congo hemorrhagic fever virus strips away immune system's defensive measures

When the alert goes out that a virus has invaded the body, cells that have yet to be attacked prepare by "armoring" themselves for combat, attaching specific antiviral molecules to many of their own proteins to help resist the invader.

13 Dec 2007

International initiative to study viruses implicated in type I diabetes launched in London

The Virus in Diabetes International Study Group (VIDIS Group) has announced its formation and plans to launch an initiative to study in detail the relation between viruses and type I diabetes in childhood.

10 Dec 2007

Safe and effective therapy discovered for patients with protein-losing enteropathy

Researchers at the Burnham Institute for Medical Research (Burnham Institute) have developed the first model to study intestinal protein leakage in mice, allowing the team to control and replicate both genetic deficiencies and environmental damages in an in vivo setting.

10 Dec 2007

Genes discovered that protect against heart damage from chemotherapy

A series of genes that protect cells from the powerful, common chemotherapeutic agent doxorubicin has been identified by researchers working to understand how the drug also can destroy the heart.

4 Dec 2007

Devastating economic impact predicted if foot-and-mouth disease arrive in Kansas

As much as $945 million. That's what agricultural economists at Kansas State University say could be the impact on Kansas' economy were there a large-scale foot-and-mouth outbreak in a region thick with livestock operations.

29 Nov 2007

Family doctors and patients with herpes are poorly informed about the viral infection

Family doctors and patients with herpes are poorly informed about the viral infection, indicate the results of an online survey, published ahead of print in the journal Sexually Transmitted Infections .

22 Nov 2007

Viral infection affects important cells' stress response

Viral infection disrupts the normal response of mammalian cells to outside deleterious forces, cleaving and inactivating a protein called G3BP that helps drive the formation of stress granules, which shelter the messenger RNAs that carry the code for protein formation, said researchers from Baylor College of Medicine in Houston.

15 Nov 2007